Evidence map›Paper›PMID 36290093›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Early Years of Carbapenem-Resistant

Tibor Pál, Aqdas B Butt, Akela Ghazawi, Jens Thomsen, Tahir A Rizvi, Ágnes Sonnevend

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. First national study on genomic profiling ofEnvironmental challenges (Amsterdam, Netherlands) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Tibor PálDepartment of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 17666, United Arab Emirates.
Aqdas B ButtDepartment of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 17666, United Arab Emirates.
Akela GhazawiDepartment of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 17666, United Arab Emirates.ORCID 0000-0003-2552-4807
Jens ThomsenAbu Dhabi Public Health Center, Abu Dhabi P.O. Box 5674, United Arab Emirates.ORCID 0000-0002-2646-9494
Tahir A RizviDepartment of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 17666, United Arab Emirates.
Ágnes SonnevendDepartment of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 17666, United Arab Emirates.ORCID 0000-0002-7065-1736
United Arab Emirates University · AE

Funding

United Arab Emirates University 31R061 and 31M316University of Pecs Kispal Gyula - 300852
6 · The paper itself

Abstract

Recent studies showed that the current endemic of carbapenem-resistant

Indexed as

carbapenemasecarbapenem-resistant EnterobacteralesKlebsiella pneumoniae clonesMiddle Eastmolecular typing

Identifiers

PMID36290093
PMCPMC9598120
OpenAlexW4306836403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.